Class Actions
Intellia Therapeutics, Inc. Class Action
Robbins LLP is Investigating Allegations that Intellia Therapeutics, Inc. (NTLA) Misled Investors Regarding the Viability of its Drug Candidate
February 12, 2025
THE NEWSROOM
Search
Categories
Archives
Investment Monitoring From Robbins LLP
To ensure your financial investments are being managed honestly, enroll in Stock Watch, our free investment monitoring service for individual and institutional investors.
Class Actions
Elastic N.V. Class Action
Robbins LLP is Investigating Allegations that Elastic N.V. (ESTC) Misled Investors Regarding the Stability of its Sales Operations
February 12, 2025
Class Actions
Edison International Class Action
Robbins LLP is Investigating Allegations that Edison International’s (EIX) Equipment May Have Been Involved in the Recent Eaton Canyon Fire
February 11, 2025
Class Actions
Icon PLC Class Action
Robbins LLP is Investigating Allegations that ICON PLC (ICLR) Misled Investors Regarding Demand
February 11, 2025
Robbins LLP News
The Future of Securities Litigation: How Technology is Reshaping the Legal Landscape
Discover how AI, blockchain, and e-discovery tools are transforming securities litigation, enhancing efficiency and reshaping legal strategies.
February 11, 2025
Class Actions
Neumora Therapeutics, Inc. Class Action
Robbins LLP is Investigating Allegations that Neumora Therapeutics, Inc. (NMRA) Misled Investors in the Offering Documents in Support of its IPO
February 10, 2025
Class Actions
Monolithic Power Systems Inc. Class Action
Robbins LLP is Investigating Allegations that Monolithic Power Systems Inc. (MPWR) Misled Investors Regarding its Products Performance and Quality Control Issues
February 5, 2025
Class Actions
GSK PLC Class Action
Robbins LLP is Investigating Allegations that GSK PLC (GSK) Misled Investors Regarding its Recall of Zantac
February 5, 2025
Class Actions
Target Corporation Class Action
Robbins LLP is Investigating Allegations that Target Corporation (TGT) Misled Investors Regarding its DEI Policies
February 4, 2025
Protect your